Showing results (21-30 of 85) with videos related to
Sort By:
Pageof 9
Pediatric Blood & Cancer|October 9, 2017
Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimenElad Jacoby, Nira Varda-Bloom, Gal Goldstein, et al.Frontiers in Immunology|July 28, 2020
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against LeukemiaMeir Rozenbaum, Amilia Meir, Yarden Aharony, et al.Current Research in Translational Medicine|December 29, 2019
Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemiaIvetta Danylesko, Guy Chowers, Roni Shouval, et al.British Journal of Haematology|February 28, 2022
Parameters of long-term response with CD28-based CD19 chimaeric antigen receptor-modified T cells in children and young adults with B-acute lymphoblastic leukaemiaElad Jacoby, Bella Bielorai, Daphna Hutt, et al.Acta Paediatrica (Oslo, Norway : 1992)|February 22, 2025
Endocrine Abnormalities and Growth Pattern in Single Large-Scale Mitochondrial DNA Deletion SyndromesAyman Daka, Einat Lahav, Omer Bar Yosef, et al.Plos One|March 3, 2012
The effect of prolonged physical activity performed during extreme caloric deprivation on cardiac functionDavid Planer, David Leibowitz, Amir Hadid, et al.Harefuah|April 15, 2024
[CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE]Uri Greenbaum, Dana Yehudai-Ofir, Ofrat Beyar Katz, et al.Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|May 17, 2020
Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patientsDaphna Hutt, Bella Bielorai, Bella Baturov, et al.Current Research in Translational Medicine|September 21, 2024
Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expressionIvetta Danylesko, Noga Shem-Tov, Ronit Yerushalmi, et al.Bone Marrow Transplantation|February 28, 2019
Early and late hematologic toxicity following CD19 CAR-T cellsShalev Fried, Abraham Avigdor, Bella Bielorai, et al.Pageof 9